Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Restore, Niagen Bioscience ...
Experimental eye treatment ...
Jupiter Neurosciences doses...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Restore, Niagen Bioscience ...
Experimental eye treatment ...
Jupiter Neurosciences doses...
Occuity
Diagnostics
Investment
Investment
Occuity publishes corneal thickness trial results
Diagnostics
Investment
Investment
Occuity inks European partnerships for handheld ophthalmic device
Diagnostics
Features
Oculomics – keeping an eye on your healthspan
Diagnostics
Occuity ramps up IP for early detection of diseases through the eye
Diagnostics
Investment
Occuity lands £343k grant to develop optical diabetes screening device
Investment
Occuity launches new investment round as it eyes up product development and new opportunity
Diagnostics
Investment
Occuity look to pet longevity, targeting diabetes management in pets
Diagnostics
Investment
Occuity raises over £2.5m for optical diabetes devices
AI/Tech
Biotech
Diagnostics
Occuity – shining a light on health and longevity
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report
